Extracellular matrix as a biological scaffold material: Structure and function.
By S. Badylak, D. Freytes, T. Gilbert. Acta Biomaterialia, 2009
1,285 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering, Surgery
View Paper: https://www.semanticscholar.org/paper/089eb3d769ba75a83f8771ea637f0fa2d7362e56
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
- Lisa J. White
- S. Velankar
- Madeline C. Cramer
- Lindsey T. Saldin
- Chaomei Chen
- Meen Chul Kim
- Rachael Dubin
- Sheila MacNeil
In Biomedical Engineering
- Chaomei Chen
- S. Bose
- Meen Chul Kim
- Rachael Dubin
- Lisa J. White
- S. Velankar
- Madeline C. Cramer
- Lindsey T. Saldin
In Surgery
- Lisa J. White
- S. Velankar
- Madeline C. Cramer
- Lindsey T. Saldin
- Chaomei Chen
- Meen Chul Kim
- Rachael Dubin
- M. Roy
Citations in the corpus
- Extracellular Matrix Hydrogels from Decellularized Tissues: Structure and Function (2016, positive): “appropriately, ECM materials harvested by such methods retain the biochemical complexity, nanostructure, and bioinductive properties of the native matrix, and have been shown to promote the in vivo creation of site-specific, functional tissue [17].”
- Challenges in the Treatment of Chronic Wounds (2015, background): “ECMs contain not only structural collagen but also glycosaminoglycans (including hyaluronan), proteoglycans, and glycoproteins—all essential components to replace the defective ECM of injured tissues.(222,223) Currently available nonhuman ECM products with clinical data to support their efficacy inc”
- Recent advances in bone tissue engineering scaffolds (2012, background): “It works as a reservoir for different cytokines and growth factors [15,16]”
- The Tissue-Engineered Vascular Graft—Past, Present, and Future (2015, background): “Muscle-derived stem cells have been utilized in successful in vivo studies of TEVGs.74 When seeded onto PEUU scaffolds and implanted in rat aortas, these constructs demonstrated patency for up to 8 weeks, integrated with the surrounding tissue, and became populated with ECs and SMCs.”
- Emerging trends and new developments in regenerative medicine: a scientometric update (2000 – 2014) (2014, methodology): “2009 Extracellular matrix as a biological scaffold material: Structure and function ACTA BIOMATER [36]”